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Acute viral bronchiolitis in young infants remains a cause of 
substantial morbidity and health care costs. It is the most common 
lower respiratory tract condition and the most common reason for 
the hospitalization of infants. A number of respiratory viruses have 
been associated with acute viral bronchiolitis although respiratory 
syncytial virus (RSV) remains the most frequently identified virus. 
The majority of affected infants have a mild self-limiting disease, 
while others have more severe illness and require hospitalization 
and,sometimes,ventilatory support. Bronchiolitis has an overall 
mortality rate of 0.2-0.5%, with 99% of deaths occurring in de-
veloping countries.
Bronchiolitis is a clinical diagnosis based on a typical pattern of 
rhinorrhoea, cough, poor feeding, tachypnoea, subcostal recession 
and auscultatory findings of wheezing and fine inspiratory crack-
les. There is a distinct seasonal pattern with a peak in incidences 
in autumn and winter.
Evidence-based reviews have suggested a limited role for 
diagnostic laboratory or radiographic tests in typical cases of 
bronchiolitis. A nasopharyngeal aspirate has been identified as 
the most sensitive methodfor virus detection. Pulse oximetry also 
provides valuable information about the severity of the disease and 
guides subsequent management.
Supportive therapy remains the major treatment option, as no 
other specific treatments to date haveshown to provide clinically 
significantbenefits. Minimal handling, oxygen supplementation, 
and appropriate fluid management (including nasogastric feeds 
if necessary) are the mainstay of therapy. Nasal suctioning can be 
helpful as well. Very young infants may require cardiopulmonary 
monitoring for apnoea. There is a wide variation in treatment for 
bronchiolitis, which has led to the development of evidence-based 
clinical practice guidelines for treatment. Bronchodilators are in-
consistently used and have been advocated for certain subgroups 
of infants. Several large, recent trials have revealed a lack of ef-
ficacy for routine use of either bronchodilators or corticosteroids 
for the treatment of bronchiolitis. Preliminary evidence suggests 
a potential future role nebulized hypertonic saline.
Key words: bronchiolitis, infants, respiratorycondition.
the role of Mycoplasma Pneumonia infection in child 
wheezing disorders
l. neamtu1, *S. Sciuca1, V. Magalu2
1Department of Pediatrics, Nicolae Testemitanu State Medical and Pharmaceutical University
2Laboratory of Immunology, Scientific Research Institute for Maternal and Child Health Care
93, Burebista Street, Chisinau, Republic of Moldova
*Corresponding author: +37379471374. E-mail: ssciuca@rambler.ru
The study was aimed to evaluate the role of the specific serolo-
gic diagnosis of Mycoplasma infection and clinical peculiarities of 
bronchopulmonary diseases with recurrent episodes of wheezing 
in children. 
Seventy-six children (ages 6 months to 7 years) with wheezing 
disorders (bronchial asthma and obstructive bronchitis) were 
included in our study. The diagnosis, classification of asthma, 
and asthma severity levels were based on GINA guidelines. The 
determination of M. pneumonia and M. hominis IgG, IgA, IgM 
antibodies were performed by using an enzyme-linked immuno-
sorbent assay (Human, Germania).
Analysis of the serologic examination results showed that 56 
patients had the Mycoplasma infection and 20 exhibited no signs of 
Mycoplasma infection. In I group (the Mycoplasma-positive group) 
4 patients had bronchial asthma, and 6 patients with obstructi-
ve bronchitis had specific antibodies in diagnostic titers (IgM 
0,35±0,01 (cut-off 0,25), IgG 0,33±0,13 (cut-off 0,30±0,03) and 
IgA 1,47±0,01 (cut-off 0,801), IgG 1,18±0,46 (cut-off 0,33±0,02) 
accordingly). In the remainder of the first group (47 children), 10 
children had b\ronchial asthma and 36 children had obstructive 
bronchitis associated with acute pneumonia. Levels of specific 
antibodies consisted of: M. pneumonia (4 children) IgM 0,29±0,02 
(cut-off 0,25), IgG 0,47±0,02 (cut-off 0,32) and M. hominis (4 
children) IgA 0,25±0,15 (cut-off 0,24), IgG 1,03±0,25; cut-off 
0,3±0,01 and in 2 children a mix infection (M. hominis and M. 
pneumonia IgG 0,80±0,2 (cut-off 0,28) and IgG 0,50±0,07 (cut-off 
0,33) accordingly) (in the group with pneumonia and bronchial 
asthma) and M. pneumonia 0,45±0,06 (cut-off 0,34), IgG 0,44±0,02 
(cut-off 0,35) and M. hominis IgM 0,34±0,09 (cut-off 0,30), IgG 
0,97±0,17 (cut-off 0,29) (in the group with pneumonia and ob-
structive bronchitis). 
In II group (the Mycoplasma-negative group) 4 patients had 
obstructive bronchitis and 16 children had pneumonia, including 
6 children with associated bronchial asthma and 10 patients had 
pneumonia with obstructive bronchitis. The levels of specific 
antibodies was below the cut-off: M. pneumonia IgM 0,18±0,09 
(cut-off 0,52±0,15), IgG 0,17±0,02 (cut-off 0,33±0,03), M. pneu-
moniae IgM 0,1±0,02 (cut-off 0,25), IgG 0,14±0,02 (cut-off 0,27) 
and in last group IgM 0,1±0,04 (cut-off 0,25) and IgG 0,17±0,04 
(cut-off 0,29) accordingly. 
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The Evolution of pneumonia in children with Mycoplasma 
infection was complicated in 11 cases: in 6 cases with pleural 
effusion and in 5 cases with atelectasia (patients from the Myco-
plasma-negative group had pleural effusion only in 2 cases).
Mycoplasma infection in children with obstructive bronchitis 
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Cystic fibrosis (CF) is a monogenic autosomal recessive dis-
order with a chronic progressive evolution, which determines an 
abnormal production of viscous secretions from the glands of 
exogenous excretion, and characterized by chronic obstructive 
pneumopathy, chronic diarrhea, malnutrition and malabsorption 
syndromes.
Respiratory symptoms onset in CF patients usually starts early 
– 80% in the first year of life with recurrent bronchitis, mostly 
with severe obstructive syndrome, latent persistent pneumonias, 
pulmonary and non-respiratory complications development. CF 
is also characterized by the installation of chronic obstructive 
pulmonary disease, which manifests itself by wheezing, prolonged 
expiration, persistent cough during respiratory infectious episodes 
which has latent evolution, nocturnal exacerbations, paroxys-
mal and exhausting evolution. Bronhoobstructive syndrome is 
develops al the level of the small bronchi and is conditioned by 
the viscous, sticky secretions and infective bacterial component. 
Expectorated secretions are abundant, purulent, in cases with 
progressive evolution haemoptysis may develop. In long-term 
evolution children develop progressive respiratory failure. The 
progressive evolution of the disease is conditioned also by resistant 
bacterial agents (S.aureus, Ps aerugenosae, H. influenzae), which 
accelerates destructive processes of the lung parenchyma and 
contribute to the expansion of the pulmonary fibrosis phenomena, 
and development of complications in the lungs (pneumothorax, 
atelectasis, bronchiectasis, bullous-distrophy, lung abscess, hae-
moptysis, asphyxia, calcinates in lungs, pulmonary hypertension 
and pulmonary heart disease).
Chest deformity is a clinical expression of the severe pulmo-
nary pathological process: thoracic cage expansion, dorsal kyp-
hosis, hypertrophic pulmonary osteoarthropathy (in schoolage 
children) which causes chest pain, bone brittleness (fragility), 
swelling, and hydrarthrosis. Chronic persistent severe hypoxia 
determines the presence in CF children of fingers hippocratism. 
ENT disorders at children with CF are presented by the nasal 
polyposis, sinusitis and chronic rhinitis, transmission deafness. 
The prognosis is reserved, with high risks of death in cases 
with severe neonatal onset. Currently the disease may have a stable 
evolution, if favorable circumstances are present: early diagnosis, 
efficient treatment with digestive enzymes, control of pulmonary 
infections, respiratory kinesiotherapy. 
Key words: cystic fibrosis, children, etiology, clinical features, 
complications, management.
and bronchial asthma is a significant risk factor, thus the identifi-
cation of this infectious agent is important for the development of 
efficient programs of treatments in pediatric pneumology.
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The aim of the study was the assessment of total immunoglo-
bulin E (IgE) in children with different phenotype of bronchial 
asthma.
This study included 122 schoolchildren (aged 6-12 years) 
with bronchial asthma, including 37 schoolchildren (30.3%) 
with intermittent asthma, 39 children (32%) with persistent mild 
asthma, 33 children (27%) with moderate persistent asthma, and 
13 children (10.7%) with severe persistent asthma. The values of 
total IgE were evaluated by the immunoenzymatic method. The 
results were statistically processed in Epi Info 3.5 program. 
The definition of the severity of bronchial asthma pheno-
type in 122 schoolchildren revealed allergen-induced bronchial 
asthma in 70.5% (86 schoolchildren); virus-induced bronchial 
asthma – in 7.4% (9 schoolchildren); bronchial asthma induced 
by physical effort – in 6.6% (8 schoolchildren) and unresolved 
asthma – in 15.6% (19 schoolchildren). The total IgE concentration 
was higher in schoolchildren with allergen-induced bronchial 
asthma (400,3±42,4 ME/ml) in comparison with IgE values in 
virus-induced bronchial asthma (45,9±3,9 ME/ml, p<0,001), in 
asthma-induced by physical effort (37,9±3,9 ME/ml, p<0,001) and 
in unspecified asthma (28,5±3,3 ME/ml, p<0,001). In this work 
we revealed significant correlation between the total serum IgE 
